Legumain expression as a prognostic factor in breast cancer patients Jessica GawendaFrank TraubReinhard von Wasielewski Preclinical Study 21 September 2006 Pages: 1 - 6
Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines Miltiadis PaliourasEleftherios P. Diamandis Preclinical Study 08 August 2006 Pages: 7 - 18
Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo Ali GhadersohiDalin PanFengzhi Li Preclinical study 08 August 2006 Pages: 19 - 30
Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer Geeta KulkarniDmitry A. TurbinJonathan M. Lee PRE-CLINICAL STUDY 09 August 2006 Pages: 31 - 41
The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers P. Kelly MarcomClaudine IsaacsMatthew J. Ellis Clinical Trial 08 August 2006 Pages: 43 - 49
The decision-making experience among women diagnosed with stage I and II breast cancer Brenda SaboNathalie St-JacquesDaniel Rayson Clinical Trial 19 July 2006 Pages: 51 - 59
Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics Guillermo CarreñoJosé M. del CasarFrancisco J. Vizoso Clinical Trial 19 July 2006 Pages: 61 - 73
Monitoring primary breast cancer throughout chemotherapy using FDG-PET Garry M. McDermottAndrew WelchSteven D. Heys Clinical Trial 09 August 2006 Pages: 75 - 84
Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women Martha L. SlatteryCarol SweeneyTim Byers Epidemiology 02 November 2006 Pages: 85 - 101
Ultrasound-guided vacuum-assisted core breast biopsy: experience with 406 cases Enrico CassanoLinei A. B. D. UrbanMassimo Bellomi EPIDEMIOLOGY 13 July 2006 Pages: 103 - 110
Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer Heather GreenleeYu ChenHabibul Ahsan Epidemiology 19 July 2006 Pages: 111 - 117
A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland Cezary CybulskiDominika WokołorczykJan Lubiński Epidemiology 08 August 2006 Pages: 119 - 122
Detection of polymorphisms in the promoters of matrix metalloproteinases 2 and 9 genes in breast cancer in South Brazil: preliminary results Adriana V RoeheAna Paula G FrazzonMarcia S Graudenz LETTER TO THE EDITOR 27 January 2007 Pages: 123 - 124
Do nipple aspirate fluid epithelial cells and their morphology predict breast cancer development? Ferdinando MannelloGaetana A. M. TontiEdward R. Sauter Letter to the Editor 19 July 2006 Pages: 125 - 127